BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21957289)

  • 1. Kaposi's sarcoma-associated herpesvirus noncoding polyadenylated nuclear RNA interacts with virus- and host cell-encoded proteins and suppresses expression of genes involved in immune modulation.
    Rossetto CC; Pari GS
    J Virol; 2011 Dec; 85(24):13290-7. PubMed ID: 21957289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of viral and cellular gene expression by Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA.
    Rossetto CC; Tarrant-Elorza M; Verma S; Purushothaman P; Pari GS
    J Virol; 2013 May; 87(10):5540-53. PubMed ID: 23468496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's Sarcoma-Associated Herpesvirus mRNA Accumulation in Nuclear Foci Is Influenced by Viral DNA Replication and Viral Noncoding Polyadenylated Nuclear RNA.
    Vallery TK; Withers JB; Andoh JA; Steitz JA
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome.
    Rossetto CC; Pari G
    PLoS Pathog; 2012; 8(5):e1002680. PubMed ID: 22589717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA.
    Massimelli MJ; Majerciak V; Kruhlak M; Zheng ZM
    J Virol; 2013 Jan; 87(1):243-56. PubMed ID: 23077296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two herpesviral noncoding PAN RNAs are functionally homologous but do not associate with common chromatin loci.
    Withers JB; Li ES; Vallery TK; Yario TA; Steitz JA
    PLoS Pathog; 2018 Nov; 14(11):e1007389. PubMed ID: 30383841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A viral nuclear noncoding RNA binds re-localized poly(A) binding protein and is required for late KSHV gene expression.
    Borah S; Darricarrère N; Darnell A; Myoung J; Steitz JA
    PLoS Pathog; 2011 Oct; 7(10):e1002300. PubMed ID: 22022268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA: a structural scaffold for nuclear, cytoplasmic and viral proteins.
    Sztuba-Solinska J; Rausch JW; Smith R; Miller JT; Whitby D; Le Grice SFJ
    Nucleic Acids Res; 2017 Jun; 45(11):6805-6821. PubMed ID: 28383682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's Sarcoma-Associated Herpesvirus K8 Is an RNA Binding Protein That Regulates Viral DNA Replication in Coordination with a Noncoding RNA.
    Liu D; Wang Y; Yuan Y
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-Wide Mapping of the Binding Sites and Structural Analysis of Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 2 Reveal that It Is a DNA-Binding Transcription Factor.
    Hu H; Dong J; Liang D; Gao Z; Bai L; Sun R; Hu H; Zhang H; Dong Y; Lan K
    J Virol; 2016 Feb; 90(3):1158-68. PubMed ID: 26537687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.
    Song MJ; Li X; Brown HJ; Sun R
    J Virol; 2002 May; 76(10):5000-13. PubMed ID: 11967316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The m
    Martin SE; Gan H; Toomer G; Sridhar N; Sztuba-Solinska J
    RNA; 2021 Sep; 27(9):1102-1125. PubMed ID: 34187903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways.
    Sahin BB; Patel D; Conrad NK
    PLoS Pathog; 2010 Mar; 6(3):e1000799. PubMed ID: 20221435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the expression and functions of the Kaposi's sarcoma-associated herpesvirus long noncoding PAN RNA.
    Conrad NK
    Virus Res; 2016 Jan; 212():53-63. PubMed ID: 26103097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor transactivates KSHV noncoding RNA PAN to promote lytic replication-mediated oncogenesis: A mechanism of sex disparity in KS.
    Ding M; Wu J; Sun R; Yan L; Bai L; Shi J; Feng H; Zhang Y; Lan K; Wang X
    PLoS Pathog; 2021 Sep; 17(9):e1009947. PubMed ID: 34543357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene.
    Chen J; Ueda K; Sakakibara S; Okuno T; Yamanishi K
    J Virol; 2000 Sep; 74(18):8623-34. PubMed ID: 10954564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAN's Labyrinth: Molecular biology of Kaposi's sarcoma-associated herpesvirus (KSHV) PAN RNA, a multifunctional long noncoding RNA.
    Rossetto CC; Pari GS
    Viruses; 2014 Nov; 6(11):4212-26. PubMed ID: 25375885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis.
    Zuo J; Hislop AD; Leung CS; Sabbah S; Rowe M
    J Virol; 2013 May; 87(10):5340-50. PubMed ID: 23449805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.